These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25223544)

  • 1. Case-base methods for studying vaccination safety.
    Saarela O; Hanley JA
    Biometrics; 2015 Mar; 71(1):42-52. PubMed ID: 25223544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study.
    Desai RJ; Glynn RJ; Wang S; Gagne JJ
    Am J Epidemiol; 2016 May; 183(10):949-57. PubMed ID: 27189330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-base sampling method for estimating recurrent event intensities.
    Saarela O
    Lifetime Data Anal; 2016 Oct; 22(4):589-605. PubMed ID: 26468012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple self-controlled case series for large-scale longitudinal observational databases.
    Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
    Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A validation sampling approach for consistent estimation of adverse drug reaction risk with misclassified right-censored survival data.
    Gravel CA; Dewanji A; Farrell PJ; Krewski D
    Stat Med; 2018 Nov; 37(27):3887-3903. PubMed ID: 30084171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suspected adverse reactions after vaccination. Results from the German Health Interview and Examination Survey for Children and Adolescents. Part 2: predictors of parental reporting of suspected adverse reactions after vaccinations].
    Poethko-Müller C; Atzpodien K; Schmitz R; Schlaud M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Mar; 54(3):365-71. PubMed ID: 21347770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Suspected adverse reactions after vaccination. Results from the German Health Interview and Examination Survey for Children and Adolescents. Part I: descriptive analyses].
    Poethko-Müller C; Atzpodien K; Schmitz R; Schlaud M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Mar; 54(3):357-64. PubMed ID: 21347769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing data privacy in matched studies via virtual pooling.
    Saha-Chaudhuri P; Weinberg CR
    BMC Med Res Methodol; 2017 Sep; 17(1):136. PubMed ID: 28882105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological assessment of an effectiveness of vaccinations].
    Zieliński A
    Przegl Epidemiol; 2001; 55(1-2):197-205. PubMed ID: 11556081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical methods for epidemiologic studies of the health effects of air pollution.
    Navidi W; Thomas D; Langholz B; Stram D
    Res Rep Health Eff Inst; 1999 May; (86):1-50; discussion 51-6. PubMed ID: 10465799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse probability weighting in nested case-control studies with additional matching--a simulation study.
    Støer NC; Samuelsen SO
    Stat Med; 2013 Dec; 32(30):5328-39. PubMed ID: 24132909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating marginal causal effects in a secondary analysis of case-control data.
    Persson E; Waernbaum I; Lind T
    Stat Med; 2017 Jul; 36(15):2404-2419. PubMed ID: 28276084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computer program to estimate power and relative efficiency of flexibly matched case-control studies.
    Stürmer T; Gefeller O; Brenner H
    Methods Inf Med; 2005; 44(5):693-6. PubMed ID: 16400378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of matched case-control data with incomplete strata: applying longitudinal approaches.
    Lin IF; Lai MY; Chuang PH
    Epidemiology; 2007 Jul; 18(4):446-52. PubMed ID: 17525695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.
    Li L; Kulldorff M; Russek-Cohen E; Kawai AT; Hua W
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1304-12. PubMed ID: 26464236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark.
    Andrews N; Stowe J; Miller E; Svanström H; Johansen K; Bonhoeffer J; Hviid A;
    Vaccine; 2012 Apr; 30(19):3042-6. PubMed ID: 21699947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-population studies in pharmacoepidemiology.
    Capellà D; Pedrós C; Vidal X; Laporte JR
    Drug Saf; 2002; 25(1):7-19. PubMed ID: 11820909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease risk estimation by combining case-control data with aggregated information on the population at risk.
    Chang X; Waagepetersen R; Yu H; Ma X; Holford TR; Wang R; Guan Y
    Biometrics; 2015 Mar; 71(1):114-121. PubMed ID: 25351292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified self-controlled case series method to examine association between multidose vaccinations and death.
    Kuhnert R; Hecker H; Poethko-Müller C; Schlaud M; Vennemann M; Whitaker HJ; Farrington CP
    Stat Med; 2011 Mar; 30(6):666-77. PubMed ID: 21337361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Logistic regression analysis of biomarker data subject to pooling and dichotomization.
    Zhang Z; Liu A; Lyles RH; Mukherjee B
    Stat Med; 2012 Sep; 31(22):2473-84. PubMed ID: 21953741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.